Percutaneous coronary intervention of a tortuous   and complex circumflex lesion using the robotic CorPath  GRX system

Zeliaś, Aleksander; Khokhar, Arif; Proniewska, Klaudia; Złahoda-Huzior, Adriana; Ruggiero, Rossella; Chandra, Kailash; Giannini, Francesco; Dudek, Dariusz

doi:10.33963/kp.a2021.0057

Cited by 5 publications

(8 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has also been reported that precise robotic lesion length measurement contributes to appropriate stent length selection [ 8 ] [ 9 ]. CorPath GRX is also useful for tortuous and complex lesions [ 10 ], and its use in carotid artery disease has recently been reported [ 11 , 12 ].…”

Section: Introductionmentioning

confidence: 99%

Periprocedural and 30-day outcomes of robotic-assisted percutaneous coronary intervention used in the intravascular imaging guidance

Koeda

Ishida

Sasaki

et al. 2022

Cardiovasc Interv and Ther

View full text Add to dashboard Cite

In recent years, there have been several reports on robotic-assisted percutaneous coronary intervention (R-PCI), but few studies have been conducted on R-PCI performed under intravascular imaging guidance. To elucidate the periprocedural and postoperative 30-day outcomes of intravascular imaging-guided R-PCI, we performed a retrospective observational study on all patients in 102 consecutive cases who underwent R-PCI under intravascular imaging guidance at a single center in Japan from June 12, 2019 to February 18, 2021. The primary end point was 30-day survival, and the secondary end point was the incidence of complications. Intravascular imaging-guided R-PCI was performed 110 times in total on 125 lesions. The medians of procedural time, fluoroscopy time, contrast volume, patient entrance skin dose, and radiation exposure to the main operator were 49 min, 16 min, 67 mL, 0.62 Gy, and 0 μSv, respectively. Furthermore, 60.0% of target lesion branches were American College of Cardiology Foundation/American Heart Association classification type B2 or type C. However, in all cases, lesion dilatation was successful, and the final Thrombolysis in Myocardial Infarction flow grade was 3. The combination of manual operation was required in 12.7% of all cases, but 30-day survival was confirmed in all cases. There were two problems at the puncture site. One small distal branch artery dissection occurred due to manual operation, but no cardiovascular events (myocardial infarction, stroke) occurred and no target lesion restenosis was observed within 30 days of R-PCI. Hence, R-PCI using intravascular imaging demonstrated highly satisfactory treatment outcomes, and no complication caused by robotic operation was observed.

show abstract

Section: Introductionmentioning

confidence: 99%

Periprocedural and 30-day outcomes of robotic-assisted percutaneous coronary intervention used in the intravascular imaging guidance

Koeda

Ishida

Sasaki

et al. 2022

Cardiovasc Interv and Ther

View full text Add to dashboard Cite

show abstract

“…A wearable surgical robot is designed, which has three 2, the main performance of the designed robot system is compared with that of other vascular interventional surgical robots. [9][10][11][12]16,26 The surgical robots that use fixed brackets and those directly integrated on the operating table are difficult to change the distance and intervention angle between the robot and the patient, which brings inconvenience to the surgery. The surgical robot using a bedside robotic arm, although capable of adjusting its posture, is too heavy.…”

Section: Discussionmentioning

confidence: 99%

“…The average accuracy of force feedback is 0.021 N, which fully meets the safety requirements of surgery. In Table 2, the main performance of the designed robot system is compared with that of other vascular interventional surgical robots 9–12,16,26 …”

Section: Discussionmentioning

confidence: 99%

“…Hansen Medical has developed the Sensei X robot system, which can navigate and control catheters, controlling it to bend at different angles 11 . The most mature is the Corpath GRX robot system developed by Corindus Corporation, which relies on a friction wheel to control the delivery and twisting of guidewires, and can quickly replace the components that hold the guidewires for rapid disinfection 12,13 . These commercial robot systems have been proved to be effective, 14,15 but they do not realize the force feedback function, and there is a significant gap with the practical operation habits of doctors.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Design and evaluation of a wearable vascular interventional surgical robot system

Yu,

Wang,

Rong

et al. 2023

Robotics Computer Surgery

View full text Add to dashboard Cite

BackgroundRemote‐controlled robotic vascular interventional surgery can reduce radiation exposure to interventional physicians and improve safety. However, inconvenient operation and lack of force feedback limit its application.Materials and MethodsA new wearable robotic system for vascular interventional surgery is designed, which is more flexible in operation. It ensures the safety of surgery through haptic force feedback. The system was evaluated by human vascular models and animal experiments.ResultsThe average static error of the system is 0.048 mm when the axial motion is 250 mm and 1.259° when the rotational motion is 400°. The average error of the force feedback is 0.021 N. The results of vascular model experiments and animal experiments demonstrate the feasibility and safety of the system.ConclusionsThe proposed robotic system can assist physicians in remotely delivering standard catheters or guidewires. The system is more flexible and uses haptic force feedback to ensure surgical safety.

show abstract

“…[ 7 – 10 ] As the number of robotic installations increases worldwide, combined with growing operator experience and technological developments, the range and complexity of lesions and procedures that can be treated robotically is rapidly expanding. [ 9 , 11 – 13 ]…”

mentioning

confidence: 99%

Latest Developments in Robotic Percutaneous Coronary Interventions

Khokhar,

Marrone,

Bermpeis

et al. 2023

Interv Cardiol

Self Cite

View full text Add to dashboard Cite

Since the first robotic-assisted percutaneous coronary intervention procedure (R-PCI) was performed in 2004, there has been a steady evolution in robotic technology, combined with a growth in the number of robotic installations worldwide and operator experience. This review summarises the latest developments in R-PCI with a focus on developments in robotic technology, procedural complexity, tele-stenting and training methods, which have all contributed to the global expansion in R-PCI.

show abstract

Percutaneous coronary intervention of a tortuous and complex circumflex lesion using the robotic CorPath GRX system

Cited by 5 publications

References 5 publications

Periprocedural and 30-day outcomes of robotic-assisted percutaneous coronary intervention used in the intravascular imaging guidance

Periprocedural and 30-day outcomes of robotic-assisted percutaneous coronary intervention used in the intravascular imaging guidance

Design and evaluation of a wearable vascular interventional surgical robot system

Latest Developments in Robotic Percutaneous Coronary Interventions

Contact Info

Product

Resources

About